Bibliographic Details
| Title: |
Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. |
| Authors: |
Fiksinski, A. M., Breetvelt, E. J., Lee, Y. J., Boot, E., Butcher, N., Palmer, L., Chow, E. W. C., Kahn, R. S., Vorstman, J. A. S., Bassett, A. S. |
| Source: |
Psychological Medicine. Apr2019, Vol. 49 Issue 6, p1047-1054. 8p. |
| Subjects: |
Genetics of schizophrenia, Schizophrenia risk factors, Adaptability (Personality), Age distribution, Cognitive testing, Factor analysis, Health status indicators, Life skills, Mathematical models, Neuropsychological tests, Memory, Psychology of movement, Psychology, Psychoses, Regression analysis, 22q11 deletion syndrome |
| Abstract: |
Background: Identifying factors that influence the functional outcome is an important goal in schizophrenia research. The 22q11.2 deletion syndrome (22q11DS) is a unique genetic model with high risk (20–25%) for schizophrenia. This study aimed to identify potentially targetable domains of neurocognitive functioning associated with functional outcome in adults with 22q11DS. Methods: We used comprehensive neurocognitive test data available for 99 adults with 22q11DS (n = 43 with schizophrenia) and principal component analysis to derive four domains of neurocognition (Verbal Memory, Visual and Logical Memory, Motor Performance, and Executive Performance). We then investigated the association of these neurocognitive domains with adaptive functioning using Vineland Adaptive Behavior Scales data and a linear regression model that accounted for the effects of schizophrenia status and overall intellectual level. Results: The regression model explained 46.8% of the variance in functional outcome (p < 0.0001). Executive Performance was significantly associated with functional outcome (p = 0.048). Age and schizophrenia were also significant factors. The effects of Executive Performance on functioning did not significantly differ between those with and without psychotic illness. Conclusion: The findings provide the impetus for further studies to examine the potential of directed (early) interventions targeting Executive Performance to improve long-term adaptive functional outcome in individuals with, or at high risk for, schizophrenia. Moreover, the neurocognitive test profiles may benefit caregivers and clinicians by providing insight into the relative strengths and weaknesses of individuals with 22q11DS, with and without psychotic illness. [ABSTRACT FROM AUTHOR] |
|
Copyright of Psychological Medicine is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Psychology and Behavioral Sciences Collection |
